Quarterly Result9 Feb 2026, 09:31 pm

Gian Life Care Ltd to Approve Q4 Results on February 14, 2026

AI Summary

Gian Life Care Ltd has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended on December 31, 2025. The meeting will take place in Kanpur. The trading window for dealing in shares of the company has been closed from January 1, 2026, for all Directors, KMP's, Designated Employees, and Connected Persons of the Company as defined in the Code. The window will remain closed until 48 hours after the information is made public.

Key Highlights

Gian Life Care Ltd to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended on December 31, 2025.
Board meeting scheduled on February 14, 2026, in Kanpur.
Trading window for dealing in shares of the company closed from January 1, 2026.
Trading window to remain closed until 48 hours after the information is made public.

View BSE Filing

GIANLIFE

Healthcare Service Provider

Gian Life Care Ltd

Price Impact